4//SEC Filing
BORKOWSKI EDWARD 4
Accession 0001387131-21-005568
CIK 0000025743other
Filed
May 11, 8:00 PM ET
Accepted
May 12, 8:39 PM ET
Size
9.2 KB
Accession
0001387131-21-005568
Insider Transaction Report
Form 4
BORKOWSKI EDWARD
Executive Vice President
Transactions
- Exercise/Conversion
Restricted Stock Units
2021-05-10−103,500→ 207,000 totalExercise: $0.00→ Common Stock (103,500 underlying) - Exercise/Conversion
Common Stock
2021-05-10+103,500→ 103,500 total - Sale
Common Stock
2021-05-11$1.04/sh−44,252$46,022→ 59,248 total
Footnotes (4)
- [F1]On May 10, 2021, the reporting person received 103,500 shares of issuer common stock in settlement of restricted stock units (RSUs), which vested on March 30, 2021.
- [F2]The reported securities represent shares of issuer common stock sold upon settlement to satisfy tax obligations.
- [F3]Each RSU represents a contingent right to receive one share of issuer common stock upon settlement.
- [F4]The RSUs vest in three equal installments annually beginning March 30, 2021, becoming fully vested on March 30, 2023.
Documents
Issuer
TherapeuticsMD, Inc.
CIK 0000025743
Entity typeother
Related Parties
1- filerCIK 0001197542
Filing Metadata
- Form type
- 4
- Filed
- May 11, 8:00 PM ET
- Accepted
- May 12, 8:39 PM ET
- Size
- 9.2 KB